Sander A. Flaum, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 13,025 shares at $42.00 ($714K) on 2015-03-20, disclosed to the SEC on 2015-12-23.
Open-market sale of $714k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 9,800 | $412K | 57.6% |
| 2 | $93.76 | 3,225 | $302K | 42.4% |
| Total | $54.82 avg | 13,025 | $714K | 100% |
| Filing → |